Drugs Affecting the Central & Autonomic Nervous System
Overview of the Nervous System
- The Nervous System is divided into two primary divisions:
- Central Nervous System (CNS): Includes the Brain and the Spinal cord.
- Peripheral Nervous System: Divided into the Somatic nervous system (affecting skeletal muscle) and the Autonomic nervous system.
- The Autonomic Nervous System is categorized into two functional branches:
- Parasympathetic (Cholinergic): Mediated by the neurotransmitter Acetylcholine (ACh).
- Sympathetic (Adrenergic): Mediated by the neurotransmitter Norepinephrine (NE). Receptors include Alpha (1, 2) and Beta (1, 2).
Autonomic Nervous System (ANS) Responses
- Parasympathetic Nervous System (PNS): Known as the "Rest and Digest" Response.
- Eyes: Constricts pupils.
- Salivary Glands: Stimulates salivation.
- Heart: Slows heartbeat.
- Lungs: Constricts bronchi.
- Stomach: Stimulates digestion.
- Liver: Stimulates bile release.
- Intestines: Stimulates peristalsis and secretion.
- Bladder: Contracts bladder.
- Anatomical components involved: Medulla Oblongata, Vagus Nerve, Ganglion.
- Sympathetic Nervous System (SNS): Known as the "Fight or Flight" Response.
- Eyes: Dilates pupils.
- Salivary Glands: Inhibits salivation.
- Heart: Accelerates heartbeat.
- Lungs: Dilates bronchi.
- Stomach: Inhibits digestion.
- Liver: Stimulates glucose release.
- Kidneys: Stimulates epinephrine and norepinephrine release.
- Intestines: Inhibits peristalsis and secretion.
- Bladder: Relaxes bladder.
- Anatomical components involved: Solar Plexus, Chain of Sympathetic Ganglia.
Neurotransmission and Receptor Mechanisms
- Neurotransmitters: These are chemical substances that enable messages to be transmitted by crossing a synapse. A transmitter can either excite or inhibit a physiological response at a receptor site through:
- Receptor binding.
- Reuptake.
- Metabolism.
- Activation of the SNS (5/19/2026):
- Direct: The drug itself attaches to the receptor and mimics the neurotransmitter.
- Indirect: Causes the release of the neurotransmitter from the pre-synaptic cleft, which then attaches to the receptor.
- Mixed: A combination of both direct and indirect mechanisms.
Sympathetic Nervous System (Adrenergic) Receptors
- Adrenergic Receptors receive catecholamines/neurotransmitters (norepinephrine and epinephrine) at specific body sites:
- Alpha1: Responsible for vasoconstriction, decreased Gastrointestinal (GI) and bladder motility, mydriasis (pupil dilation), decreased secretions, ejaculation, uterine contractions, and glycogenolysis.
- Alpha2: Located on the presynaptic nerve; functions to inhibit the SNS response.
- Beta1: Primarily affects the heart, causing increased heart rate, contraction, and conduction.
- Beta2: Causes bronchodilation, uterine relaxation, glycogenolysis, and decreased GI motility.
- Dopaminergic Receptors: Respond to the catecholamine dopamine.
- Increases blood flow to the brain, heart, kidneys, and viscera.
- At high doses, these receptors cause vasoconstriction.
Parasympathetic Nervous System (Cholinergic) Receptors
- Cholinergic Receptors receive the neurotransmitter acetylcholine (ACh):
- Muscarinic: Increases GI and bladder motility, increases secretions, constricts pupils (miosis), causes bronchoconstriction, and decreases heart rate, contraction, and conduction.
- Nicotinic receptors.
Rationales for Receptor Selectivity and Drug Actions
- Receptor Selectivity: This allows drugs to alter biological activity at specific receptors without affecting others, resulting in fewer side effects and a more therapeutic outcome.
- Agonists: Drugs that activate receptors.
- Antagonists: Drugs that inhibit or block receptor activation.
- General Pharmacological Actions:
- Increase or decrease neurotransmitter synthesis.
- Promote or inhibit the release of neurotransmitters.
- Activate receptors by binding (agonists).
- Block activation of receptors (antagonists).
- Block or promote neurotransmitter reuptake.
- Inactivate or promote enzymes that metabolize neurotransmitters.
Adrenergic Agonists (Sympathomimetics)
- Mechanism of Action: These drugs mimic the actions of norepinephrine (NE), epinephrine (Epi), and dopamine on Alpha1, Alpha2, Beta1, Beta2, and dopaminergic receptors.
- Physiological "Fight or Flight" Effects: Increased visual acuity, alertness, and muscle strength.
- Pharmacokinetics: Characterized by a rapid onset and a shorter half-life.
- Clinical Indications:
- Respiratory: Asthma and bronchitis (via Beta2 bronchodilation); Example: Albuterol (Ventolin).
- Nasal Congestion: Vasoconstriction of nasal arterioles (via Alpha1); Example: Phenylephrine (Neo-Synephrine).
- Ophthalmic: Conjunctival congestion, glaucoma, and mydriasis for eye exams (via Alpha1 or Beta2); Example: Epinephrine (Adrenalin).
- Cardiovascular: Heart failure, shock, and surgery (vasoactive/cardioselective effects via Alpha1, Beta1, Beta2, and dopaminergic receptors).
- Dobutamine (Dobutrex).
- Dopamine (Intropin).
- Norepinephrine (Levophed).
- Midodrine (ProAmatine): Specifically treats hypotension.
- Epinephrine (Adrenalin): Emergency use for anaphylactic shock.
Adrenergic Agonist Side Effects and Considerations
- Side Effects:
- CNS Stimulation: Headache (HA), restlessness, insomnia, etc.
- Cardiovascular: Chest pain, vasoconstriction, Hypertension (HTN), tachycardia, palpitations, and dysrhythmias.
- Other: Sweating, nausea/vomiting, muscle cramps, and decreased urinary output.
- Warning: Monitor for IV infiltration to minimize tissue necrosis from leakage.
- Geriatric Considerations (5/19/2026):
- Decreased efficiency of the heart; stress, heat, and Beta agonists can lead to HTN.
- Decreased baroreceptor sensitivity can lead to orthostatic hypotension.
Nursing Management for Adrenergic Agonists
- Nursing Activities:
- Collect a thorough health history and physical assessment.
- Monitor Blood Pressure (BP), Heart Rate (HR), breath sounds, peripheral pulses, skin color, capillary refill, and mental status.
- Assess for sensitivity to light, nausea, constipation, and urinary output.
- Always use an IV pump and assess the IV site frequently.
- Patient Education:
- Wear Medic-Alert bracelets.
- Instruction on equipment use and prevention measures for respiratory patients.
Adrenergic Antagonists (Sympatholytics)
- Mechanism of Action: These drugs "lyse" or inhibit SNS stimulation by blocking adrenergic receptors.
- Alpha-blockers: Inhibit Alpha1 receptors.
- Beta-blockers: Inhibit Beta1 and/or Beta2 receptors.
- Alpha 1 Blockers:
- Action: Blocks the typical SNS vasoconstriction response, leading to vasodilation.
- Indications:
- HTN: Doxazosin (Cardura) causes arterial and venous dilation.
- Benign Prostatic Hyperplasia (BPH) and Urinary Obstruction: Tamsulosin (Flomax) decreases resistance to urinary outflow in males.
- Tissue Necrosis: Phentolamine (Regitine), a potent vasodilator, is used for extravasation of IV alpha adrenergics.
- Side Effects: Severe hypotension (leading to falls or passing out) and orthostatic hypotension.
- Nursing Activities: Assess BP while sitting and standing; assess apical HR for 1minute.
- Education: Stand slowly; avoid excessive heat, exercise, and alcohol.
Beta-Adrenergic Blockers
- Functional Specificity:
- Beta1 Blockers: Affect the heart; slow HR, conduction, and contractility.
- Beta2 Blockers: Affect the lungs; block bronchodilation, narrowing airways and increasing shortness of breath.
- Indications: Angina, Myocardial Infarction (MI), dysrhythmias, HTN, Heart Failure (HF), and migraine headaches.
- Carvedilol (Coreg).
- Metoprolol (Lopressor).
- Propranolol (Inderal): Noted for lipophilicity, allowing it to enter the CNS easily.
- Contraindications:
- Drug allergies, Heart block, slow HR, low BP, pregnancy, pulmonary disease, and caution in diabetics.
- Side Effects:
- Bradycardia, decreased cardiac output/hypotension, bronchoconstriction, and hypoglycemia.
Nursing Management for Beta Blockers
- Nursing Activities:
- Monitor BP and apical HR for 1minute.
- Assess breath sounds.
- Education Provided to Clients:
- Do not abruptly discontinue taking medications.
- Monitor daily weights.
- Prevent constipation by increasing fiber and fluids.
- Be aware the drug may cause depression and possible sexual dysfunction.
- Avoid excessive heat, exercise, and alcohol.
- Consider wearing a Medic-Alert bracelet.
Cholinergic Agonist Drugs (Parasympathomimetics)
- Mechanism of Action: Mimic the neurotransmitter acetylcholine (ACh) at muscarinic and nicotinic receptors.
- "Rest and Digest" Response (5/19/2026):
- Increased GI motility and contraction of the bladder.
- Constriction of the pupil (miosis).
- Decreased heart rate and dilation of blood vessels.
- Constriction of the bronchioles.
- Direct-Acting Cholinergics:
- Indications: Glaucoma, eye surgery, xerostomia (dry mouth), urinary retention, and GI/bladder atony.
- Bethanechol (Urecholine).
- Indirect-Acting Cholinergics (Acetylcholinesterase inhibitors):
- Indications: Myasthenia gravis (rapid weakness of voluntary muscles) and Alzheimer’s (decreased ACh levels).
- Pyridostigmine (Mestinon) for Myasthenia gravis.
- Donepezil (Aricept) and Memantine (Namenda) for Alzheimer’s.
- Contraindications:
- Drug allergy, GI or GU obstruction, gastric ulcers, bradycardia, hypotension, and pulmonary disorders.
Side Effects and Nursing Management for Cholinergic Agonists
- Side Effects: Hypotension, bradycardia, syncope, diarrhea, blurred vision, difficulty breathing, and urinary frequency.
- Toxicity (Cholinergic Crisis): Identified by the acronym SLUDGE:
- Salivation.
- Lacrimation.
- Urinary incontinence.
- Diarrhea.
- GI cramps.
- Emesis.
- Nursing Activities:
- Post-surgery: Walk the patient, provide high fiber foods and hydration.
- Monitor for urinary output, bowel movements (BM), increased muscle strength, and improved memory.
- Assess lung sounds and vital signs.
- Administer drugs with meals to reduce GI upset.
- Assist with walking, dressing, and toileting.
- Patient Education:
- Avoid abrupt withdrawal of meds.
- Change positions slowly.
- Connect with community resources (Alzheimer’s support, Meals on Wheels, prescription assistance).
Anticholinergic Drugs (Antagonists)
- Action: Parasympatholytic; inhibits the rest and digest response. Competitively blocks ACh at muscarinic receptors.
- Physiological Responses (Dose Dependent):
- Heart: Blocks slowing; increases HR, conduction, and contraction.
- Lungs: Blocks bronchoconstriction; results in bronchodilation.
- GI Tract: Blocks increased motility; results in decreased motility.
- Bladder: Blocks bladder emptying; results in bladder retention.
- Eye: Blocks pupil constriction; results in dilation.
- Glands: Blocks secretions; results in decreased secretions.
- CNS: Low dose results in decreased muscle rigidity/tremors; high dose results in drowsiness, disorientation, and hallucinations.
- Indications:
- Parkinson's and Extrapyramidal symptoms from antipsychotic drugs.
- Eye exams.
- Irritable bowel and diarrhea: Dicyclomine (Bentyl).
- Incontinence and neurogenic bladder: Oxybutynin (Ditropan).
- Bradycardia and heart blocks: Atropine (AtroPen).
- Asthma, bronchitis, and emphysema.
- Reducing secretions (mouth, nose, bronchi) for common colds or surgery: Glycopyrrolate (Robinul).
- Side Effects: Dry mouth, blurred vision, urinary retention, constipation, and tachycardia.
Nursing Management for Anticholinergic Drugs
- Nursing Activities (5/19/2026):
- Monitor patterns of bowel movements and urinary output.
- Monitor heart rate.
- Prevent constipation.
- Oral Care: Provide oral care; suggest chewing gum or sucking on hard candy; ensure fluids are available.
- Dermal Patch: Apply to dry, non-hairy, non-irritated area; rotate sites.
- Eye Drops: Apply light pressure to the inner canthus for 30−60seconds; advise wearing sunglasses in light.
- Patient Education:
- Avoid extreme heat and exercise.
- Drugs may cause drowsiness.